Poor judgement and awkward questions on conference call
The FDA told them what they wanted--a study with all tumors injected at the high dose, and tracking of clinical symptoms (pain, bleeding, infection). PVCT refused to listen. What worries me even more is that they did not disclose the FDA letter. I think they must have gotten the email on May 16 and they got the hard copy May 21, and they did the press release on May 21 saying that the FDA had not reported back to them.
I think this ensures that PVCT will be sued. All of this is going to create a ton of negative publicity. I can understand why they did not want to disclose the denial on the day of the listing, but they should have disclosed on the Monday. Everyone will wonder if management can be trusted, especially with PumpStopper and Adam F saying that they are crooks. Very depressing.
God knows what they will come up with for the Conference Call. I cannot think of anything that will help. They are going to be asked some awkward questions about the letter.
People on the board have been saying that the BTD request was a waste of time, and I now think they were right. It would have been better to wait for the release of the ASCO abstracts and the listing, and then announce a phase 3 after the ASCO presentations.
Now do you believe me they used multiple ids? Everything I question was dead on. I got lured in on the fact maybe, they needed to explain MOA. I dropped my guard. Were is the gene man and derrick, jxboxtas, headhunter, pallen1, lugs, pvctguru?